You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 10, October 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Obesity
 •Bariatric Surgery
 •Gastrointestinal/ Upper Foregut
 •Surgical Cytokines
 •Public Health
 •Alert me on articles by topic

Increased Gastric Cytokine Production After Roux-en-Y Gastric Bypass for Morbid Obesity

Joel Faintuch, MD, PhD; Robson K. Ishida, MD; Mioko Jacabi, PhD; Adriana S. Ribeiro, MD, PhD; Rogerio Kuga, MD; Paulo Sakai, MD, PhD; Hermes V. Barbeiro, PhD; Denise F. Barbeiro, PhD; Francisco G. Soriano, MD, PhD; Ivan Cecconello, MD, PhD

Arch Surg. 2007;142(10):962-968.

Hypothesis  Mucosal cytokines may be involved in the process of gastric bacterial contamination that may occur after Roux-en-Y bypass for morbid obesity in both gastric chambers, with inflammation and gastritis mostly in the excluded stomach.

Design  A prospective observational study in a homogeneous population with nonspecific complaints.

Setting  Outpatient clinic of a large, public, academic hospital.

Patients  Subjects (n = 37; 26 [70.3%] female; mean ± SD age, 42.4 ± 9.9 years) seen a mean ± SD of 7.3 ± 1.4 years after Roux-en-Y gastric bypass and nonoperated on morbidly obese control subjects (n = 10; 7 [70%] female; mean ± SD age, 44.0 ± 8.9 years).

Intervention  Enteroscopy was performed to collect samples for cytokine assays and bacteriologic studies.

Main Outcome Measures  Concentrations of tumor necrosis factor {alpha} and transforming growth factor β in the gastric mucosa of both chambers in patients undergoing Roux-en-Y gastric bypass and correlation with bacterial overgrowth and Helicobacter pylori infection.

Results  High microbial counts (>105 colony-forming units per milliliter) were detected in 22 (59.5%) and 7 (18.9%) of the 37 samples from the functional pouch and excluded reservoir, respectively; and H pylori investigation was positive in 6 of 37 samples (16.2%). The tumor necrosis factor {alpha} concentration (mean ± SD, 2.1 ± 1.9 pg/g of protein) and the transforming growth factor β concentration (mean ± SD, 24.2 ± 12.8 pg/g of protein) in the excluded stomach, but not in the proximal pouch, were elevated with regard to the corpus or antrum of controls, and correlation with bacterial overgrowth and with H pylori infection was demonstrated.

Conclusion  Overexpression of tumor necrosis factor {alpha} and transforming growth factor β occurred in the distal stomach, positive cytokine correlation with microbial invasion by H pylori and nonspecific germs was seen, and further studies addressing phenotypic and genotypic changes of gastric mucosa are recommended.


Author Affiliations: Department of Gastroenterology (Drs Faintuch and Cecconello) and Endoscopy Service (Drs Ishida, Ribeiro, Kuga, and Sakai), Hospital das Clinicas; Food Microbiology Section, Instituto Adolfo Lutz (Dr Jacabi); and Research Laboratory LIM 51, São Paulo University Medical School (Drs H. V. Barbeiro, D. F. Barbeiro, and Soriano), São Paulo, Brazil.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bariatric Surgery in the New Millennium
Livingston
Arch Surg 2007;142:919-922.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.